Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mertens

Showing results (141-150 of 211) with videos related to

Pageof 22
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 15, 2022
Cost-analysis of robot-assisted radical cystectomy in Europe: A cross-country comparisonGeorges Mjaess, Romain Diamand, Fouad Aoun, et al.
European Urology Oncology|June 21, 2024
Clinical Validation of the Intermediate-risk Non-muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group CollaborationFrancesco Soria, Matteo Rosazza, Simone Livoti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2024
Platinum-Based Chemotherapy Induces Opposing Effects on Immunotherapy Response-Related Spatial and Stromal Biomarkers in the Bladder Cancer MicroenvironmentMaksim A Chelushkin, Jeroen van Dorp, Sandra van Wilpe, et al.
The American Journal of Surgical Pathology|July 1, 2025
International Society of Urological Pathology Consensus Meeting 2024: Working Group 2 Preneoplastic and Precursor Lesions of the Urinary BladderMichelle R Downes, Antonio Lopez-Beltran, Roberto Contieri, et al.
European Urology Open Science|May 15, 2023
Carboplatin Induction Chemotherapy in Clinically Lymph Node-positive Bladder CancerMarkus von Deimling, Laura S Mertens, Bas W G van Rhijn, et al.
Targeted Oncology|November 13, 2024
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysisTakafumi Yanagisawa, Keiichiro Mori, Akihiro Matsukawa, et al.
BJU International|July 9, 2025
Impact of timing of computed tomography staging and patient factors on the detection of 'true' cN+ bladder cancerMarkus von Deimling, Marc Furrer, Alberto Bianchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2025
Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO StudyChantal F Stockem, Alberto Gil-Jimenez, Hamza Ali, et al.
Cancers|October 14, 2023
Comparing Robotic-Assisted to Open Radical Cystectomy in the Management of Non-Muscle-Invasive Bladder Cancer: A Propensity Score Matched-Pair AnalysisEtienne Courboin, Romain Mathieu, Valentina Panetta, et al.
European Journal of Immunology|August 20, 2019
Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndromeMaarten van der Kroef, Lucas L van den Hoogen, Jorre S Mertens, et al.
Pageof 22

Showing results (141-150 of 211) with videos related to

Sort By:
Pageof 22
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 15, 2022
Cost-analysis of robot-assisted radical cystectomy in Europe: A cross-country comparisonGeorges Mjaess, Romain Diamand, Fouad Aoun, et al.
European Urology Oncology|June 21, 2024
Clinical Validation of the Intermediate-risk Non-muscle-invasive Bladder Cancer Scoring System and Substratification Model Proposed by the International Bladder Cancer Group: A Multicenter Young Academic Urologists Urothelial Working Group CollaborationFrancesco Soria, Matteo Rosazza, Simone Livoti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2024
Platinum-Based Chemotherapy Induces Opposing Effects on Immunotherapy Response-Related Spatial and Stromal Biomarkers in the Bladder Cancer MicroenvironmentMaksim A Chelushkin, Jeroen van Dorp, Sandra van Wilpe, et al.
The American Journal of Surgical Pathology|July 1, 2025
International Society of Urological Pathology Consensus Meeting 2024: Working Group 2 Preneoplastic and Precursor Lesions of the Urinary BladderMichelle R Downes, Antonio Lopez-Beltran, Roberto Contieri, et al.
European Urology Open Science|May 15, 2023
Carboplatin Induction Chemotherapy in Clinically Lymph Node-positive Bladder CancerMarkus von Deimling, Laura S Mertens, Bas W G van Rhijn, et al.
Targeted Oncology|November 13, 2024
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysisTakafumi Yanagisawa, Keiichiro Mori, Akihiro Matsukawa, et al.
BJU International|July 9, 2025
Impact of timing of computed tomography staging and patient factors on the detection of 'true' cN+ bladder cancerMarkus von Deimling, Marc Furrer, Alberto Bianchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 9, 2025
Biomarker Analysis and Treatment Dynamics Following Preoperative Ipilimumab plus Nivolumab in Locally Advanced Urothelial Cancer from the Phase IB NABUCCO StudyChantal F Stockem, Alberto Gil-Jimenez, Hamza Ali, et al.
Cancers|October 14, 2023
Comparing Robotic-Assisted to Open Radical Cystectomy in the Management of Non-Muscle-Invasive Bladder Cancer: A Propensity Score Matched-Pair AnalysisEtienne Courboin, Romain Mathieu, Valentina Panetta, et al.
European Journal of Immunology|August 20, 2019
Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndromeMaarten van der Kroef, Lucas L van den Hoogen, Jorre S Mertens, et al.
Pageof 22